SLC1A6 and nasopharyngeal carcinoma: Increased gamma-H2AX (γH2AX) expression, a biomarker of DNA damage, was noticed in radioresistant NPC cells by knocking down SLC1A6, followed by cisplatin or radiation treatment (Figures 3G,H).